Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP1 | P24666 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30454780 | 1.00 | ACP1 (0.46) | ACP1CYP1A2TSHRTDP1CYP3A4 | |
| SCHEMBL6735075 | 0.82 | MAPT (0.38) | ACP1CYP1A2TSHRTDP1CYP3A4 | |
| SCHEMBL22651898 | 0.80 | RORC (0.38) | ACP1CYP1A2TSHRTDP1CYP3A4 | |
| SCHEMBL8979233 | 0.79 | ALDH1A1 (0.38) | ACP1CYP1A2TSHRTDP1CYP3A4 | |
| SCHEMBL5539229 | 0.79 | ESR1 (0.39) | ACP1CYP1A2TSHRTDP1CYP3A4 | |
| SCHEMBL17479870 | 0.79 | HDAC6 (0.45) | ACP1CYP1A2TSHRTDP1CYP3A4 | |
| SCHEMBL28122138 | 0.79 | ESR1 (0.39) | ACP1CYP1A2TSHRTDP1CYP3A4 | |
| SCHEMBL1201242 | 0.78 | ALDH1A1 (0.46) | ACP1TSHRTDP1MAPK1CLK4 | |
| SCHEMBL29987688 | 0.78 | ALDH1A1 (0.46) | ACP1TSHRTDP1MAPK1CLK4 | |
| SCHEMBL2093130 | 0.77 | ESR1 (0.38) | ACP1CYP1A2TSHRTDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3717457-A1 | PROCESS FOR PREPARATION OF ENZALUTAMIDE USING NOVEL INTERMEDIATE | Aarti Industries Limited (IN) | 2020-10-07 | — | — | EP | claimed |
| US-20250369146-A1 | AMMONIUM SALT COMPOUND, ADDITIVE FOR ELECTROLYTIC COPPER PLATING, ELECTROLYTIC COPPER PLATING SOLUTION COMPOSITION AND ELECTROLYTIC COPPER PLATING METHOD | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-12-04 | — | — | US | disclosed |
| EP-4139308-B1 | PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2024-07-17 | — | — | EP | disclosed |
| WO-2023188949-A1 | SECONDARY BATTERY ELECTROLYTE AND SECONDARY BATTERY | 株式会社村田製作所 | 2023-10-05 | — | — | WO | disclosed |
| US-20230284516-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-07 | — | — | US | disclosed |
| US-20230200211-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-22 | — | — | US | disclosed |
| EP-3717457-B1 | PROCESS FOR PREPARATION OF ENZALUTAMIDE USING NOVEL INTERMEDIATE | AARTI INDUSTRIES LTD (IN) | 2023-06-21 | — | — | EP | disclosed |
| US-20220396596-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-12-15 | — | — | US | disclosed |
| US-20220223790-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-07-14 | — | — | US | disclosed |
| WO-2021223736-A1 | COMPOUNDS AS BCL-2 INHIBITORS | FOCHON PHARMACEUTICALS, LTD. (CN) | 2021-11-11 | — | — | WO | disclosed |
| US-7173032-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-02-06 | — | — | US | disclosed |
| US-7173032-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-02-06 | — | — | US | disclosed |
| EP-0144206-B1 | PROCESS FOR SYNTHESISING SQUARAINE COMPOSITIONS | XEROX CORPORATION (US) | 1989-04-19 | — | — | EP | disclosed |
| EP-0146301-B1 | PROCESS FOR SYNTHESIZING SQUARAINE COMPOSITIONS | XEROX CORPORATION (US) | 1988-07-13 | — | — | EP | disclosed |
| US-4606986-A | Electrophotographic elements containing unsymmetrical squaraines | XEROX CORPORATION (US) | 1986-08-19 | — | — | US | disclosed |
| EP-0146301-A1 | Process for synthesizing squaraine compositions | XEROX CORPORATION (US) | 1985-06-26 | — | — | EP | disclosed |
| EP-0144206-A2 | Process for synthesising squaraine compositions | XEROX CORPORATION (US) | 1985-06-12 | — | — | EP | disclosed |
| US-4523035-A | BLUE AND GREEN PIGMENTS | XEROX CORPORATION (US) | 1985-06-11 | — | — | US | disclosed |
| US-4521621-A | Novel squarine systems | XEROX CORPORATION (US) | 1985-06-04 | — | — | US | disclosed |
| US-4096185-A | P-CHLOROBENZOTRIFLUORIDE, AMMONIA, COPPER COMPOUND CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396596-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, DRD3 | ACP1 3717/4885CYP1A2 817/4885TSHR 2845/4885 |
| US-20230284516-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, LBR, C1R | ACP1 3099/4885CYP1A2 902/4885TSHR 190/4885 |
| US-20220223790-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO2A1, SLCO4C1, TMEM109 | ACP1 3138/4885CYP1A2 1059/4885TSHR 4512/4885 |
| US-20230200211-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OPRM1, OCIAD1 | ACP1 3005/4885CYP1A2 432/4885TSHR 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.